{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:29:45Z","timestamp":1768681785029,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.clon.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T20:23:34Z","timestamp":1572726214000},"page":"e102-e110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evolving Practice Patterns Over Two Decades (1993\u20132013) in the Management of Desmoid-type Fibromatosis in British Columbia"],"prefix":"10.1016","volume":"32","author":[{"given":"A.","family":"de Bruyns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"MacNeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Clarkson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.L.","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.clon.2019.10.005_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/ejso.2001.1169","article-title":"Desmoid tumours","volume":"27","author":"Shields","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.clon.2019.10.005_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/gcc.22272","article-title":"Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis","volume":"54","author":"Crago","year":"2015","journal-title":"Genes Chromosom Cancer"},{"issue":"13","key":"10.1016\/j.clon.2019.10.005_bib3","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1245\/s10434-013-3197-x","article-title":"Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought","volume":"20","author":"Bonvalot","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.clon.2019.10.005_bib4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1245\/s10434-016-5159-6","article-title":"Toward observation as first-line management in abdominal desmoid tumors","volume":"23","author":"Burtenshaw","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clon.2019.10.005_bib5","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejca.2014.11.019","article-title":"Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients","volume":"51","author":"Colombo","year":"2015","journal-title":"Eur J Cancer"},{"issue":"25","key":"10.1016\/j.clon.2019.10.005_bib6","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1805052","article-title":"Sorafenib for advanced and refractory desmoid tumors","volume":"379","author":"Gounder","year":"2018","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.clon.2019.10.005_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejca.2014.11.005","volume":"51","author":"Kasper","year":"2015","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.clon.2019.10.005_bib8","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/annonc\/mdx323","article-title":"An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)\/Soft Tissue and Bone Sarcoma Group (STBSG)","volume":"28","author":"Kasper","year":"2017","journal-title":"Ann Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.clon.2019.10.005_bib9","article-title":"Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","year":"2014","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clon.2019.10.005_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/annonc\/mdt485","article-title":"Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm \u2013 a position paper from the Italian and the French Sarcoma Group","volume":"25","author":"Gronchi","year":"2014","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clon.2019.10.005_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/SLA.0b013e31828c8a30","article-title":"A\u00a0prognostic nomogram for prediction of recurrence in desmoid fibromatosis","volume":"258","author":"Crago","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.clon.2019.10.005_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2017.06.017","article-title":"Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma Group","volume":"83","author":"Penel","year":"2017","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.clon.2019.10.005_bib13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1245\/s10434-018-6408-7","article-title":"Systematic review of clinical outcomes following various treatment options for patients with extraabdominal desmoid tumors","volume":"25","author":"Smith","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.clon.2019.10.005_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.soc.2016.05.010","article-title":"Desmoid-type fibromatosis: evolving treatment standards","volume":"25","author":"Fiore","year":"2016","journal-title":"Surg Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.clon.2019.10.005_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejso.2018.09.015","article-title":"Surgical excision versus observation as initial management of desmoid tumors: a population based study","volume":"45","author":"Turner","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.clon.2019.10.005_bib16","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2005.04.0717","article-title":"Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)","volume":"24","author":"Heinrich","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2019.10.005_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2017.02.001","article-title":"Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG)","volume":"76","author":"Kasper","year":"2017","journal-title":"Eur J Cancer"},{"issue":"19","key":"10.1016\/j.clon.2019.10.005_bib18","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1158\/1078-0432.CCR-10-1177","article-title":"Efficacy of imatinib in aggressive fibromatosis: results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial","volume":"16","author":"Chugh","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"26","key":"10.1016\/j.clon.2019.10.005_bib19","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1056\/NEJMc1702562","article-title":"Desmoid tumors and celecoxib with sorafenib","volume":"376","author":"Benech","year":"2017","journal-title":"New Engl J Med"},{"issue":"12","key":"10.1016\/j.clon.2019.10.005_bib20","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1158\/1078-0432.CCR-10-3322","article-title":"Activity of sorafenib against desmoid tumor\/deep fibromatosis","volume":"17","author":"Gounder","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.clon.2019.10.005_bib21","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s10637-013-0023-z","article-title":"Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF\/GETO)","volume":"31","author":"Valentin","year":"2013","journal-title":"Invest New Drugs"},{"issue":"2","key":"10.1016\/j.clon.2019.10.005_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00256-009-0801-z","article-title":"Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors","volume":"39","author":"Kujak","year":"2010","journal-title":"Skeletal Radiol"},{"issue":"1","key":"10.1016\/j.clon.2019.10.005_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2214\/AJR.15.14391","article-title":"Percutaneous cryoablation of extraabdominal desmoid tumors: a 10-year experience","volume":"207","author":"Schmitz","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clon.2019.10.005_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejca.2016.04.015","article-title":"Innovative radiotherapy of sarcoma: proton beam radiation","volume":"62","author":"DeLaney","year":"2016","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.clon.2019.10.005_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.clon.2019.10.005_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10985-007-9065-x","article-title":"Generalized linear mixed models: a review and some extensions","volume":"13","author":"Dean","year":"2007","journal-title":"Lifetime Data Anal"},{"issue":"4","key":"10.1016\/j.clon.2019.10.005_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/bjs.10477","article-title":"Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis","volume":"104","author":"Janssen","year":"2017","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.clon.2019.10.005_bib28","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00000658-199906000-00014","article-title":"The enigma of desmoid tumors","volume":"229","author":"Lewis","year":"1999","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.clon.2019.10.005_bib29","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1111\/j.1463-1318.2011.02758.x","article-title":"Anti-oestrogen therapy in the treatment of desmoid tumours: a systematic review","volume":"13","author":"Bocale","year":"2011","journal-title":"Colorectal Dis"},{"issue":"2","key":"10.1016\/j.clon.2019.10.005_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/annonc\/mdg064","article-title":"The pharmacological treatment of aggressive fibromatosis: a systematic review","volume":"14","author":"Janinis","year":"2003","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.clon.2019.10.005_bib31","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/pbc.24457","article-title":"Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study","volume":"60","author":"Skapek","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.clon.2019.10.005_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/PPO.0000000000000254","article-title":"Long-term efficacy of methotrexate plus vinblastine\/vinorelbine in a large series of patients affected by desmoid-type fibromatosis","volume":"23","author":"Palassini","year":"2017","journal-title":"Cancer J"},{"issue":"1","key":"10.1016\/j.clon.2019.10.005_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/annonc\/mdr051","article-title":"Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG)","volume":"23","author":"Garbay","year":"2012","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.clon.2019.10.005_bib34","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.25089","article-title":"Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)","volume":"116","author":"de Camargo","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clon.2019.10.005_bib35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/sj.bjc.6605783","article-title":"Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis","volume":"103","author":"Dufresne","year":"2010","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clon.2019.10.005_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10637-013-0059-0","article-title":"A\u00a0prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis","volume":"32","author":"Jo","year":"2014","journal-title":"Invest New Drugs"},{"issue":"6","key":"10.1016\/j.clon.2019.10.005_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26968","article-title":"Pazopanib therapy for desmoid tumors in adolescent and young adult patients","volume":"65","author":"Agresta","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"10.1016\/j.clon.2019.10.005_bib38","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.2016.71.1994","article-title":"Clinical activity of the gamma-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis)","volume":"35","author":"Kummar","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.clon.2019.10.005_bib39","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/annonc\/mdt254","article-title":"Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis \u2013 an EORTC STBSG and ROG study (EORTC 62991-22998)","volume":"24","author":"Keus","year":"2013","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.clon.2019.10.005_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.clon.2018.05.002","article-title":"Radiation therapy as an alternative treatment for desmoid fibromatosis","volume":"30","author":"Hong","year":"2018","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.clon.2019.10.005_bib41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00066-016-1091-8","article-title":"Radiotherapy in desmoid tumors: treatment response, local control, and analysis of local failures","volume":"193","author":"Santti","year":"2017","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.clon.2019.10.005_bib42","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ijrobp.2017.12.259","article-title":"Radiation therapy for aggressive fibromatosis: the association between local control and age","volume":"100","author":"Bates","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2019.10.005_bib43","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ijrobp.2018.12.012","article-title":"Long-term outcomes for patients with desmoid fibromatosis treated with radiation therapy: a 10-year update and re-evaluation of the role of radiation therapy for younger patients","volume":"103","author":"Bishop","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clon.2019.10.005_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198134","article-title":"Optimal radiotherapy strategy for primary or recurrent fibromatosis and long-term results","volume":"13","author":"Choi","year":"2018","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.clon.2019.10.005_bib45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5152\/balkanmedj.2016.140560","article-title":"The role of radiotherapy in the treatment of primary or recurrent desmoid tumors and long-term results","volume":"33","author":"Ergen","year":"2016","journal-title":"Balkan Med J"},{"issue":"4","key":"10.1016\/j.clon.2019.10.005_bib46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamaoncol.2018.6449","article-title":"Treatment of desmoid tumors in 2019","volume":"5","author":"Gronchi","year":"2019","journal-title":"JAMA Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519304522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519304522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:47:44Z","timestamp":1760543264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655519304522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0936655519304522"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2019.10.005","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving Practice Patterns Over Two Decades (1993\u20132013) in the Management of Desmoid-type Fibromatosis in British Columbia","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}